-
Abstract Number: PB0154
Haematological, Coagulation and Biochemical Abnormalities in Covid-19 Patients in India: Do We Behave Differently?
-
Abstract Number: PB0620
Haemophilia A Genotyping in Patients with Discrepancy in FVIII Activity Levels Measured with One-stage and Chromogenic Assays
-
Abstract Number: OC 18.3
Haemostatic Components Are Associated with Risk of Venous Thromboembolism after Lower Leg Trauma
-
Abstract Number: PB0289
Haemostatic Dysfunctions in COVID-19 Infection: A Systematic Review
-
Abstract Number: PB0286
Head-to-Head Comparison of Cytokines Storm-induced Coagulopathy in Septic Shock and Covid-19
-
Abstract Number: PB0572
Health Care Resource Use (HRU) among Adult Persons with Hemophilia A (PwHA) and Concurrent Joint Disease (JD) in the United States
-
Abstract Number: PB0571
Health Care Resource Use (HRU) among Adult Persons with Hemophilia B (PwHB) and Concurrent Joint Disease (JD) in the United States
-
Abstract Number: PB1288
Heavy Menstrual Bleeding: Knowledge and Practice Assessment among Tunisian Primary Care Physicians
-
Abstract Number: PB0283
Hematologic Abnormalities in Moderate Forms of Covid-19
-
Abstract Number: PB0282
Hematologic Parameters of Ghanaian COVID-19 Patients at Diagnosis
-
Abstract Number: PB0350
Hemolysis Interference in the Anti-Xa Heparin Activity Assay
-
Abstract Number: PB1044
Hemophagocytic Lymphohistiocytosis Complicating Systemic Diseases
-
Abstract Number: PB0507
Hemophilia A Patients with Factor Ⅷ Inhibitor Feature Reduced Levels of CD4+CD25+CD127- Treg Cells and Plasma IL-35
-
Abstract Number: PB0635
Hemophilia and Concussion Outcome Study (HeCos): Neurological Status of Children with Hemophilia – Prevalence and Relevance of Mild Traumatic Brain Injury
-
Abstract Number: PB0523
Hemophilia Treatment in 2021: Choosing the ‘Optimal’ Treatment Using an Integrative, Patient-orientated Approach to Shared Decision-making between Patients and Clinicians
-
Abstract Number: PB0209
Hemoreologic Disorders in COVID-19 Patients
-
Abstract Number: PB0710
Hemorrhagic Adventitious Bursitis of the Foot in a Patient with Congenital Type 3 von Willebrand Disease
-
Abstract Number: PB0900
Hemorrhagic Phenotype in Pediatric Patients with Glanzmann Thrombasthenia (GT)
-
Abstract Number: PB0055
HemosIL Liquid Anti-Xa Apixaban Measurement in Patients with High Risk of Major Bleeding
-
Abstract Number: PB0162
Hemostasiological Blood Properties in Patients with COVID-19 Associated Viral Pneumonia
-
Abstract Number: PB0272
Hemostasis Abnormalities in Post-COVID-19 Syndrome
-
Abstract Number: PB0266
Hemostasis Disorder in COVID-19 Patients: Disseminated Intravascular Clotting (DIC)?
-
Abstract Number: PB0239
Hemostastatic Alterations with Disease Severity in the Early Symptomatic Phase of COVID-19
-
Abstract Number: PB0325
Hemostatic and Thrombogenic Properties of Lyophilized Human Platelets
-
Abstract Number: PO121
Hemostatic Defects Associated with IgA Monoclonal Gammopathy
-
Abstract Number: PB0181
Hemostatic Disorders Are Associated with the Course and Outcomes of COVID-19
-
Abstract Number: PB0451
Hemostatic Effect of Tranexamic Acid Combined with Emicizumab in Prophylactic Setting in Severe Hemophilia A: A Preclinical Study
-
Abstract Number: PB0435
Hemostatic Evaluation by Global Coagulation Assays in Patients with Acquired Hemophilia A: Analysis of Multi Centers in Japan
-
Abstract Number: PB0758
Hemostatic Evaluation by Thromboelastography in Patients from a Peruvian Oncologic Center
-
Abstract Number: PO123
Hemostatic Function in Patients with Factor XI Deficiency
-
Abstract Number: PB1142
Hemostatic Genetic Risk Factors of Aseptic Cerebral Venous Thrombosis
-
Abstract Number: OC 50.2
Hemostatic Profile of COVID-19 Convalescent Plasma (CCP) Donors from Bergamo Area
-
Abstract Number: OC 67.1
Hemostatic Response is Maintained for up to 5 Years Following Treatment with Valoctocogene Roxaparvovec, an AAV5-hFVIII-SQ Gene Therapy for Severe Hemophilia A
-
Abstract Number: OC 59.3
Hemostatic Treatment of Patients with Rare Bleeding Disorders in the Netherlands: Real-life Data from the RBiN Study
-
Abstract Number: PB0343
Heparin Interference of the Thrombin Generation Assay Can Be Eliminated by Heparinase Treatment
-
Abstract Number: OC 27.3
Heparin Modulates FV Procofactor Regulatory Region and Susceptibility to APC
-
Abstract Number: PB1275
Heparin Therapeutic Range for Five aPTT Reagents in Plasma and One Point of Care
-
Abstract Number: PB0127
Heparin-binding Copolymer Completely Reverses the Anticoagulant Effect of Subcutaneously Administered Enoxaparin in Mice
-
Abstract Number: PB0259
Heparin-induced Thrombocytopenia (HIT) during Extracorporeal Membrane Oxygenation (ECMO) in COVID-19: A Case Report
-
Abstract Number: PB0702
Hereditary Haemorrhagic Telangiectasia (HHT) or Rendu-Osler Weber Disease as an Important Rare Haemorrhagic Disorder in Costa Rica: A Report of Costa Rica
-
Abstract Number: PB1315
Hereditary Thrombophilia in Macedonian Women with in vitro Fertilization Failure
-
Abstract Number: PB1164
Heterozygosity for factor V Leiden with a Catastrophic Presentation
-
Abstract Number: PO154
Heterozygous FV Leiden Mutation Associated with Multiple Cerebral Venous Thrombosis in Childhood. A Case Report
-
Abstract Number: PB0001
High Concentration of Symmetric Dimethylarginine is Associated with Low Platelet Reactivity and Increased Bleeding Risk in Patients with Acute Coronary Syndrome
-
Abstract Number: LPB0115
High Impact and Severe Outcomes of Intracranial Hemorrhage (ICH) in an Italian Population of Adult Mild Hemophiliac Patients: Data from the EMO.REC Registry
-
Abstract Number: PB0174
High Incidence and Early Presence of arterial thrombotic events in a COVID-19 hospitalized population: an overlooked problem?
-
Abstract Number: PB0936
High Plasma von Willebrand Factor Level is Associated with Increased Risk of upper Gastrointestinal Bleeding in Patients with Chronic Coronary Syndromes Receiving Long-term Antiplatelet Therapy
-
Abstract Number: PB0030
High Shear Conditions Takes Place at the Edge of the Wound after Human and Mouse Vessel Injury
-
Abstract Number: OC 04.1
High Throughput Sequencing for the Molecular Diagnosis of Inherited Platelet Disorders in Spain. Experience of the GEAPC Group
-
Abstract Number: OC 04.2
High-sensitivity Platelet Proteomics Maps the Response to Different Levels of Thrombin
-
Abstract Number: PB0688
High-throughput Screening for Pharmacological Enhancers of Mutated Factor VII Activity
-
Abstract Number: PB0970
Highly Reactive Juvenile Platelets Express Higher Levels of GPVI in a Size-related Manner
-
Abstract Number: OC 54.3
Histidine-rich Glycoprotein Attenuates Catheter Thrombosis in Rabbits
-
Abstract Number: LPB0050
History of Cancer is Associated with Increased Platelet Activity and Atherothrombosis in Patients with Peripheral Artery Disease
-
Abstract Number: PB0842
HIV is Not the Trigger for HIV-associated TTP
-
Abstract Number: PB0113
HIV-1 and SARS-CoV-2 Both Cause Protein S, but through Different Mechanisms
-
Abstract Number: PO118
Homocysteine Exchange in Athletes in the Arctic Region
-
Abstract Number: PB1285
Hormonal Contraception (HC) and Thrombosis: Identifying the Gaps in Knowledge among Young Woman
-
Abstract Number: PB1202
How Common Are Uterine Venous Plexus Thrombi in Women Attending the Gynaecology Clinic?
-
Abstract Number: PO170
How to Use the Data about Risk Factors for Thrombosis in Practice
-
Abstract Number: LPB0026
How to Use Thrombolytic Agents in the Treatment of Neonatal Thrombosis: A Systematic Review
-
Abstract Number: PB0698
Human Fibrinogen Concentrate for Bleeding Prophylaxis During Surgery in Adult, Adolescent and Pediatric Patients with Congenital Fibrinogen Deficiency: Results from the FORMA-02 and FORMA-04 Clinical Trials
-
Abstract Number: PB0765
Human Myeloperoxidase Enhances Thrombin Induced Phosphatidylserine Exposure in Human Platelets through Tyrosine Kinase/Calcium/Potassium Channels-mediated Pathway
-
Abstract Number: PB0206
Hypercoagulability Detected by Seer Sonorheometry in Covid-19 Patients at Hospital Admission
-
Abstract Number: PB0226
Hypercoagulable Rotational Thromboelastometry NaHEPTEM Profile is Related to Mechanical Ventilation Requirement among Critically ill COVID-19 Patients
-
Abstract Number: PB0215
Hypercoagulation by Rotational Thromboelastometry (ROTEM) Predicts Mortality in COVID-19: A Prospective Observational Study
-
Abstract Number: PB1205
Hypoalbuminemia, Not Proteinuria, Is Associated with Increased Venous Thromboembolism Risk among Primary Glomerulonephritis Patients with Nephrotic Syndrome: A Meta-analysis of Cohort Studies
ISTH 2021 Congress
July 17-21, 2021. Philadelphia, PA.